These stimulate intestinal L-cells through nutrient sensing and short-chain fatty acid production from bacterial fermentation
Never share your GLP-1 medication with others, even if they have the same diagnosis, as dosing must be individualized and gradually escalated under medical supervision
About the GEMINI-1 Clinical Trial The GEMINI-1 clinical trial was a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study (NCT06396429) conducted by Hengrui in China to evaluate the efficacy and safety of HRS9531 injection in adults (18 years of age) with obesity (BMI 28 kg/m 2 ) or overweight (BMI 24 kg/m 2 ) and at least one weight-related comorbidity without diabetes
While many users tolerate these peptides well, potential side effects can include nausea, dizziness, or injection site reactions
Always maintain proper hydration when using creatine, as semaglutide can mask thirst cues
Food doesnt make you bad or good